» Articles » PMID: 31475096

Approach to Cytological Indeterminate Thyroid Nodules

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2019 Sep 3
PMID 31475096
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The indeterminate thyroid nodules diagnosed by fine-needle aspiration cytology (FNAC)represents a problem for both cytopathologists and clinicians. The former sometimes use this diagnostic category as a sort of basket, putting in cases that they do not know exactly how to classify. The latter are faced with a highly variable risk of malignancy and consequently the management remains a challenge. On the histopathological side, the new WHO classification of tumors of the thyroid introduced the concept of tumors with uncertain and low malignant potential, and the concept of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), whose prognosis and management are still to be completely elucidated. While the risk of malignancy of the indeterminate diagnostic category has decreased due to the re-classification of certain types of papillary thyroid carcinomas of the follicular variant into a low malignant potential form (the NIFTP), cases diagnosed cytologically as indeterminate will probably increase in the future to avoid false positive diagnosis. Thus, the indeterminate thyroid diagnostic category still remains a challenge, both at the diagnostic level and for its management. The new version of the Bethesda system for reporting thyroid cytopathology suggests managing these patients with a repeat FNA, diagnostic lobectomy and/or molecular testing.

Citing Articles

Histopathological findings of 687 thyroid nodules, suspicious for malignancy on ultrasound, with an indeterminate cytopathological diagnosis after the combination of the Bethesda System and mutation status.

Meng X, Hou R, Zhang M, Chen J, Zhang K, Li J Cytojournal. 2025; 22:1.

PMID: 39958882 PMC: 11829308. DOI: 10.25259/Cytojournal_97_2024.


Gray zone Bethesda category III - Atypia of undetermined significance lesions of the thyroid: Potential diagnostic issues and image morphometry as a useful adjunct to cytomorphology.

Saini T, Kundu R, Rohilla M, Gupta P, Gupta N, Srinivasan R Cytojournal. 2024; 21:38.

PMID: 39563672 PMC: 11574686. DOI: 10.25259/Cytojournal_86_2023.


Enhancing diagnostic precision in thyroid nodule assessment: evaluating the efficacy of a novel cell preservation technique in fine-needle aspiration cytology.

Streinu D, Neagoe O, Borlea A, Icma I, Derban M, Stoian D Front Endocrinol (Lausanne). 2024; 15:1438063.

PMID: 39280002 PMC: 11393782. DOI: 10.3389/fendo.2024.1438063.


Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach.

Carsote M, Ciobica M, Sima O, Ciuche A, Popa-Velea O, Stanciu M Cancers (Basel). 2024; 16(10).

PMID: 38791947 PMC: 11120123. DOI: 10.3390/cancers16101868.


Integrated Diagnostics of Thyroid Nodules.

Giovanella L, Campenni A, Tuncel M, Petranovic Ovcaricek P Cancers (Basel). 2024; 16(2).

PMID: 38254799 PMC: 10814240. DOI: 10.3390/cancers16020311.


References
1.
Ophir J, Alam S, Garra B, Kallel F, Konofagou E, Krouskop T . Elastography: ultrasonic estimation and imaging of the elastic properties of tissues. Proc Inst Mech Eng H. 1999; 213(3):203-33. DOI: 10.1243/0954411991534933. View

2.
Mendez W, Rodgers S, Lew J, Montano R, Solorzano C . Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules. Ann Surg Oncol. 2008; 15(9):2487-92. DOI: 10.1245/s10434-008-0052-6. View

3.
Rago T, Vitti P . Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008; 22(6):913-28. DOI: 10.1016/j.beem.2008.09.016. View

4.
Bomeli S, LeBeau S, Ferris R . Evaluation of a thyroid nodule. Otolaryngol Clin North Am. 2010; 43(2):229-38, vii. PMC: 2879398. DOI: 10.1016/j.otc.2010.01.002. View

5.
Bongiovanni M, Krane J, Cibas E, Faquin W . The atypical thyroid fine-needle aspiration: past, present, and future. Cancer Cytopathol. 2011; 120(2):73-86. DOI: 10.1002/cncy.20178. View